The MATIC-2 is a multicenter clinical trial enrolling children who are less than 18 years of age with hemorrhagic shock potentially needing significant blood t…

Hemorrhagic ShockTrauma Injury

~Estimated

~$10 – $7,500

Philip SpinellaNCT06070350

Cryo-FIRST: Cryoprecipitate For Immediate Resuscitation in Severe Trauma: Effectiveness of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT Fibrinogen Complex, IFC) for Treatment of Trauma Associated Hemorrhage

The objective of this multicenter, single-arm, observational study is to determine the feasibility and effectiveness of early administration of FDA-approved, p…

HypofibrinogenemiaHemorrhageTrauma Associated Hemorrhage+1 more

~Estimated

~$10 – $8,750

Cerus CorporationNCT07218185

Observational

Reducing Exsanguination Via In-Vivo Expandable Foam

The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabd…

Hemorrhagic ShockTraumaExsanguinating Hemorrhage+1 more

~Estimated

~$10 – $8,750

Arsenal Medical, Inc.NCT02880163